Cerner Beats Analyst Estimates on EPS
Cerner (NAS: CERN) reported earnings on April 25. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended March 30 (Q1), Cerner missed estimates on revenues and beat expectations on earnings per share.
Compared to the prior-year quarter, revenue grew. Non-GAAP earnings per share grew significantly. GAAP earnings per share grew significantly.
Margins grew across the board.
Cerner recorded revenue of $680.0 million. The 18 analysts polled by S&P Capital IQ expected to see sales of $708.4 million on the same basis. GAAP reported sales were 8.0% higher than the prior-year quarter's $629.7 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $0.66. The 19 earnings estimates compiled by S&P Capital IQ predicted $0.63 per share. Non-GAAP EPS of $0.66 for Q1 were 22% higher than the prior-year quarter's $0.54 per share. GAAP EPS of $0.62 for Q1 were 22% higher than the prior-year quarter's $0.51 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 81.3%, 460 basis points better than the prior-year quarter. Operating margin was 23.0%, 280 basis points better than the prior-year quarter. Net margin was 16.2%, 210 basis points better than the prior-year quarter. (Margins calculated in GAAP terms.)
Next quarter's average estimate for revenue is $727.1 million. On the bottom line, the average EPS estimate is $0.68.
Next year's average estimate for revenue is $3.00 billion. The average EPS estimate is $2.81.
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 406 members out of 453 rating the stock outperform, and 47 members rating it underperform. Among 133 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 127 give Cerner a green thumbs-up, and six give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Cerner is outperform, with an average price target of $92.97.
Is Cerner the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add Cerner to My Watchlist.
The article Cerner Beats Analyst Estimates on EPS originally appeared on Fool.com.Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.